David Rescott
Stock Analyst at Robert W. Baird
(3.99)
# 1,791
Out of 5,116 analysts
259
Total ratings
49.2%
Success rate
7.2%
Average return
Main Sectors:
Stocks Rated by David Rescott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Upgraded: Buy | $87 → $116 | $100.82 | +15.06% | 23 | Nov 5, 2026 | |
| LIVN LivaNova | Reiterated: Buy | $76 → $111 | $91.14 | +21.79% | 24 | Nov 5, 2026 | |
| INSP Inspire Medical Systems | Reiterated: Hold | $59 → $77 | $66.53 | +15.74% | 21 | Nov 3, 2026 | |
| MMSI Merit Medical Systems | Reiterated: Buy | $98 → $107 | $89.62 | +19.39% | 15 | Oct 30, 2026 | |
| RMD ResMed | Reiterated: Hold | $213 → $246 | $239.31 | +2.80% | 11 | Oct 30, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $56 → $51 | $44.64 | +14.25% | 30 | Oct 29, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $121 → $123 | $113.60 | +8.27% | 2 | Oct 22, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $500 → $550 | $468.52 | +17.39% | 19 | Oct 21, 2026 | |
| MDT Medtronic | Reiterated: Hold | $85 → $100 | $104.84 | -4.62% | 25 | Sep 2, 2026 | |
| HAE Haemonetics | Reiterated: Buy | $96 → $119 | $124.11 | -4.12% | 8 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 → $165 | $130.19 | +26.74% | 31 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $28 → $20 | $20.27 | -1.33% | 3 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 → $122 | $68.98 | +76.86% | 8 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $51.95 | -34.55% | 1 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $345 → $374 | $321.11 | +16.47% | 26 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $111.13 | n/a | 1 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $26 | $24.27 | n/a | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $32.22 | n/a | 1 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 | $106.85 | n/a | 1 | Dec 21, 2021 |
Edwards Lifesciences
Nov 5, 2026
Upgraded: Buy
Price Target: $87 → $116
Current: $100.82
Upside: +15.06%
LivaNova
Nov 5, 2026
Reiterated: Buy
Price Target: $76 → $111
Current: $91.14
Upside: +21.79%
Inspire Medical Systems
Nov 3, 2026
Reiterated: Hold
Price Target: $59 → $77
Current: $66.53
Upside: +15.74%
Merit Medical Systems
Oct 30, 2026
Reiterated: Buy
Price Target: $98 → $107
Current: $89.62
Upside: +19.39%
ResMed
Oct 30, 2026
Reiterated: Hold
Price Target: $213 → $246
Current: $239.31
Upside: +2.80%
Boston Scientific
Oct 29, 2026
Reiterated: Buy
Price Target: $56 → $51
Current: $44.64
Upside: +14.25%
Abbott Laboratories
Oct 22, 2026
Reiterated: Buy
Price Target: $121 → $123
Current: $113.60
Upside: +8.27%
Intuitive Surgical
Oct 21, 2026
Reiterated: Buy
Price Target: $500 → $550
Current: $468.52
Upside: +17.39%
Medtronic
Sep 2, 2026
Reiterated: Hold
Price Target: $85 → $100
Current: $104.84
Upside: -4.62%
Haemonetics
Aug 21, 2026
Reiterated: Buy
Price Target: $96 → $119
Current: $124.11
Upside: -4.12%
Aug 7, 2026
Reiterated: Buy
Price Target: $175 → $165
Current: $130.19
Upside: +26.74%
Aug 5, 2026
Reiterated: Hold
Price Target: $28 → $20
Current: $20.27
Upside: -1.33%
Aug 5, 2026
Reiterated: Buy
Price Target: $140 → $122
Current: $68.98
Upside: +76.86%
Jul 30, 2026
Initiated Coverage: Buy
Price Target: $34
Current: $51.95
Upside: -34.55%
Jan 15, 2026
Downgraded: Hold
Price Target: $345 → $374
Current: $321.11
Upside: +16.47%
Apr 24, 2025
Reiterated: Hold
Price Target: n/a
Current: $111.13
Upside: n/a
Feb 28, 2023
Reiterated: Buy
Price Target: $17 → $26
Current: $24.27
Upside: n/a
Dec 21, 2021
Reiterated: Buy
Price Target: $75
Current: $32.22
Upside: n/a
Dec 21, 2021
Reiterated: Buy
Price Target: $145
Current: $106.85
Upside: n/a